GW869682

· GlaxoSmithKline

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for GW869682, covering 2015-04-15 to 2015-04-15. Get the full timeline:

Most recent: Clinical Trial Update: Weight Loss In Obese Subjects Taking Either GW869682 Or Placebo 3 Times Per Day For 12 Weeks [Phase 2]